Hyasynth ( SOSV Accelerator)

Funding Details
Awarder
SOSV
Date Award
May 13, 2024
Vertical
Human Health
Funding URL
View Funding Page

Company Info
Founding Year
Not provided in the memo
Organizations Involved
Not provided in the memo
Founders
Zach Wiltshire, Kevin Chen, Shoham Mookerjee, Alex Campbell
Company Description
Despite its increasing popularity in medicine, cannabis is too costly to produce at a large scale with the quality and consistency needed for medical use. Instead of depending on the cannabis plant and breeding new strains, we use engineered yeast to produce the same products, including THC, CBD, and even many of the minor cannabinoids, which are only found in small quantities in the plant. Compared to plants, our process is exponentially cheaper and faster while also giving patients, doctors, and researchers the quality they can depend on.
Market
Therapeutics
Location
Canada
Coinvestors
Not provided in the memo

Links
Back to Home Back to Human Health Deals View Funding Announcement